Rockley Group

CHAIN Biotechnology Ltd. is a biotechnology company based in London, United Kingdom, that specializes in harnessing Clostridium bacteria for various applications. Founded in 2014, the company focuses on advancing fermentation processes through synthetic biology and automation, particularly utilizing Clostridium strains to produce chiral chemicals. These chemicals are incorporated into a range of products, including nutraceuticals, personal healthcare items, pharmaceuticals, and fragrances. Notable developments include 3-hydroxybutyrate and (R)-methyl-3HB, a precursor used in glaucoma treatment. CHAIN Biotechnology also aims to create cost-effective fermentation routes from sugar. In addition to its work in fermentation, the company is exploring microbiome therapeutics, developing novel compounds aimed at treating chronic gut-related diseases using its proprietary drug development platform.

Green Biologics is a UK-based industrial biotechnology company that develops and manufactures renewable solvents and specialty chemicals through fermentation of biomass. Its portfolio includes renewable butanol, acetone, and C4 derivatives, as well as GreenFlame charcoal lighting fluids. The products support markets across paints, coatings, adhesives and inks; personal care, cosmetics and fragrances; food and flavor ingredients; health and nutrition; household and industrial cleaners; and other industrial applications. The company uses fermentation platforms to convert biomass into renewable fuels and chemicals, enabling customers to access sustainable solvents and ingredients derived from feedstocks such as corn and cellulosic materials. Operations include pilot, demo and lab facilities in the United States, with executive offices in the United Kingdom and satellite offices in China, Brazil and India. The company was incorporated in 2002 and is based in Abingdon, United Kingdom.